Literature DB >> 12506137

Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli.

Hiroshi Kawachi1, Hiroko Koike, Hidetake Kurihara, Tatsuo Sakai, Fujio Shimizu.   

Abstract

Podocin is identified as a product of the gene mutated in a patient with autosomal recessive steroid-resistant nephrotic syndrome. Although podocin is reported to be located at the slit diaphragm area, the precise role of podocin for maintaining the barrier function of the slit diaphragm has not been clearly elucidated. A rat homologue of podocin was cloned, and the expression of podocin was investigated and then compared with the nephrin and the ZO-1 expressions in rat experimental proteinuric models and in developing glomeruli. Amino acid sequences of rat and human podocin are highly homologous (84.3% identity). The domain structure of podocin is also highly conserved between rat and human. The mRNA expression for podocin was detected in glomeruli and the nerve tissues. The localization of podocin has close proximity to that of nephrin in normal adult rat glomeruli. Podocin staining was restricted to the basal side of the podocyte of the early developing stage, whereas nephrin staining was detected on the basolateral surface of podocyte. The redistribution of podocin was observed in the anti-nephrin antibody (ANA)-induced nephropathy and puromycin aminonucleoside (PAN) nephropathy. The redistribution of podocin paralleled with nephrin in ANA nephropathy but not in PAN nephropathy. Podocin is observed at the site of tight junction newly formed in proteinuric state in PAN nephropathy. It is postulated that podocin is one of the critical components of a slit diaphragm for maintaining the barrier function of the glomerular capillary wall.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12506137     DOI: 10.1097/01.asn.0000037401.02391.76

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

1.  Marker expression, behaviors, and responses vary in different lines of conditionally immortalized cultured podocytes.

Authors:  Seetharamaiah Chittiprol; Phylip Chen; Danica Petrovic-Djergovic; Tad Eichler; Richard F Ransom
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-01

Review 2.  Genetics of idiopathic nephrotic syndrome.

Authors:  Abhay N Vats
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

3.  Common variation in GPC5 is associated with acquired nephrotic syndrome.

Authors:  Koji Okamoto; Katsushi Tokunaga; Kent Doi; Toshiro Fujita; Hodaka Suzuki; Tetsuo Katoh; Tsuyoshi Watanabe; Nao Nishida; Akihiko Mabuchi; Atsushi Takahashi; Michiaki Kubo; Shiro Maeda; Yusuke Nakamura; Eisei Noiri
Journal:  Nat Genet       Date:  2011-03-27       Impact factor: 38.330

4.  The reno-protective effect of a phosphoinositide 3-kinase inhibitor wortmannin on streptozotocin-induced proteinuric renal disease rats.

Authors:  Sang Hoon Kim; Young Woo Jang; Patrick Hwang; Hyun Jung Kim; Gi Yeon Han; Chan Wha Kim
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

Review 5.  Therapeutic target for nephrotic syndrome: Identification of novel slit diaphragm associated molecules.

Authors:  Yoshiyasu Fukusumi; Naoko Miyauchi; Taeko Hashimoto; Akira Saito; Hiroshi Kawachi
Journal:  World J Nephrol       Date:  2014-08-06

6.  Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats.

Authors:  Tomonosuke Someya; Kazunari Kaneko; Toshiyuki Yamada; Yuichiro Yamashiro
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

7.  Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus.

Authors:  P Wei; P R Grimm; D C Settles; C R Balwanz; B J Padanilam; S C Sansom
Journal:  Ren Fail       Date:  2009       Impact factor: 2.606

8.  Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure rats.

Authors:  Kumiko Nishihara; Satohiro Masuda; Shunsaku Nakagawa; Atsushi Yonezawa; Takaharu Ichimura; Joseph V Bonventre; Ken-ichi Inui
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-13

9.  Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.

Authors:  Tadashi Okada; Toshifumi Sakaguchi; Ikuji Hatamura; Fumie Saji; Shigeo Negi; Haruhisa Otani; Yasuteru Muragaki; Hiroshi Kawachi; Takashi Shigematsu
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

Review 10.  Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.

Authors:  Hiroshi Kawachi; Koichi Suzuki; Naoko Miyauchi; Taeko Hashimoto; Yasuhiro Otaki; Fujio Shimizu
Journal:  Clin Exp Nephrol       Date:  2009-03-07       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.